TuHURA Biosciences (HURA) Preferred Dividend Payments (2016 - 2026)
TuHURA Biosciences' (HURA) quarterly Preferred Dividend Payments came in at $2089.0 in Q1 2026, little changed year-on-year from $2089.0 in Q1 2025, and little changed quarter-over-quarter from $2089.0 in Q4 2025.
TuHURA Biosciences (HURA) Preferred Dividend Payments (2016 - 2026) Analysis & Trends
TuHURA Biosciences' Preferred Dividend Payments history runs 11 years deep, the most recent figure standing at $2089.0 for Q1 2026.
- On a quarterly basis, Preferred Dividend Payments changed 0.0% year-over-year to $2089.0 in Q1 2026; TTM through Mar 2026 was $8356.0, a 40.69% decrease from a year earlier, with the FY2025 full-year figure at $8356.0, up 300.0% from the prior year.
- Preferred Dividend Payments held at $2089.0 in Q1 2026 per HURA's latest filing, from $2089.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $6000.0 in Q1 2024 and bottomed at $2000.0 in Q1 2022.
- The 5-year median for Preferred Dividend Payments is $2044.5 (2022), against an average of $2460.4.
- Across the five-year window, Preferred Dividend Payments jumped 200.0% in 2024 and slumped 65.18% in 2025, its largest moves.
- Year by year, Preferred Dividend Payments stood at $2000.0 in 2022, then soared by 100.0% to $4000.0 in 2023, then sank by 50.0% to $2000.0 in 2024, then grew by 4.45% to $2089.0 in 2025, then changed by 0.0% to $2089.0 in 2026.
- Per Business Quant, the three latest HURA Preferred Dividend Payments figures stand at $2089.0 (Q1 2026), $2089.0 (Q4 2025), and $2089.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | 2,089.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,089.00 |
| Dec 31, 2025 | 2,089.00 |
| Sep 30, 2025 | 2,089.00 |
| Jun 30, 2025 | 2,089.00 |
| Mar 31, 2025 | 2,089.00 |
| Sep 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | -3.17 Mn |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Sep 30, 2020 | 5,000.00 |